Our hitherto all time favourite examiner Christine Foster is in immediate danger of losing that Status. The recent development in the Exclusion NGAL-patent shows that the USPTO are still reluctant to grant the patent.

In the case of the ratio patent I think the advantage was/is  that the patent is indeed defining a measured ratio, whereas in the case of the cut-off patent as well as the exclusion patent, the USPTO  the NGAL measurements is just a law of nature…

This is however not a final rejection – but I see this more as a exchange of views – but I think its fair to say that Ms. Foster is not thrilled or convinced 🙂

Exclusion Patent – non final rejection

About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂


Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.